ロード中...

Clinical Outcomes Observed among Biopsy Proven Lupus Nephritis Patients Treated with Mycophenolate Mofetil as First-line Therapy

Background and objective The rate of end-stage renal disease from lupus nephritis has not declined, in spite of recent advances in therapeutics, such as mycophenolate mofetil (MMF). To provide insight into rates of the clinical outcomes in current practice after biopsy-proven lupus nephritis, we use...

詳細記述

保存先:
書誌詳細
出版年:Cureus
主要な著者: Timlin, Homa, Magder, Laurence, Petri, Michelle
フォーマット: Artigo
言語:Inglês
出版事項: Cureus 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5796813/
https://ncbi.nlm.nih.gov/pubmed/29410944
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.1907
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!